BridgeBio Pharma, Inc. financial data

Symbol
BBIO on Nasdaq
Location
3160 Porter Dr., Suite 250, Palo Alto, CA
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Oct 29, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 453 % +9.09%
Quick Ratio 6.69 %
Debt-to-equity -156 % +2.05%
Operating Margin -172 % +31%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 193M shares +1.97%
Common Stock, Shares, Outstanding 193M shares +1.93%
Entity Public Float 3.73B USD +79.7%
Common Stock, Value, Issued 200K USD +2.56%
Weighted Average Number of Shares Outstanding, Basic 192M shares +1.77%
Weighted Average Number of Shares Outstanding, Diluted 192M shares +1.77%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 354M USD +62.5%
Cost of Revenue 14.9M USD +525%
Research and Development Expense 466M USD -7.99%
Costs and Expenses 964M USD +26.4%
Operating Income (Loss) -610M USD -12%
Nonoperating Income (Expense) -194M USD -298%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -186M USD -13.5%
Income Tax Expense (Benefit) 1.71M USD
Earnings Per Share, Basic -4 USD/shares -74%
Earnings Per Share, Diluted -4 USD/shares -74%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 643M USD +141%
Marketable Securities, Current 7.94M USD -80.1%
Accounts Receivable, after Allowance for Credit Loss, Current 117M USD
Inventory, Net 24.5M USD
Assets, Current 839M USD +88.8%
Property, Plant and Equipment, Net 5.83M USD -33%
Operating Lease, Right-of-Use Asset 6.55M USD +1.77%
Intangible Assets, Net (Excluding Goodwill) 28.8M USD +17.4%
Other Assets, Noncurrent 25.5M USD +25.8%
Assets 998M USD +50.1%
Accounts Payable, Current 18.7M USD +40%
Employee-related Liabilities, Current 56.2M USD +29%
Contract with Customer, Liability, Current 9.09M USD
Liabilities, Current 217M USD +55.6%
Contract with Customer, Liability, Noncurrent 13.1M USD
Operating Lease, Liability, Noncurrent 3.43M USD -41.2%
Other Liabilities, Noncurrent 679K USD +80.1%
Liabilities 2.92B USD +55.1%
Accumulated Other Comprehensive Income (Loss), Net of Tax 2K USD -60%
Retained Earnings (Accumulated Deficit) -3.63B USD -28.2%
Stockholders' Equity Attributable to Parent -1.93B USD -57.2%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest -1.92B USD -57.7%
Liabilities and Equity 998M USD +50.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -199M USD +9.25%
Net Cash Provided by (Used in) Financing Activities 60.3M USD -78.4%
Net Cash Provided by (Used in) Investing Activities -1.6M USD -107%
Common Stock, Shares Authorized 500M shares 0%
Common Stock, Shares, Issued 200M shares +2.59%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -141M USD -270%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 645M USD +58.2%
Interest Paid, Excluding Capitalized Interest, Operating Activities 23.3M USD -34.1%
Deferred Tax Assets, Valuation Allowance 727M USD +8.22%
Deferred Tax Assets, Gross 729M USD +7.38%
Operating Lease, Liability 8.72M USD -16.4%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -797M USD -81.6%
Lessee, Operating Lease, Liability, to be Paid 9.47M USD -18.2%
Operating Lease, Liability, Current 5.29M USD +15.1%
Lessee, Operating Lease, Liability, to be Paid, Year Two 582K USD -74.5%
Lessee, Operating Lease, Liability, to be Paid, Year One 5.38M USD +5.21%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure +16.1%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 745K USD -34.6%
Lessee, Operating Lease, Liability, to be Paid, Year Three 454K USD -2.16%
Deferred Tax Assets, Operating Loss Carryforwards 379M USD +5.62%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 25M shares 0%
Unrecognized Tax Benefits 36.9M USD +19.5%
Lessee, Operating Lease, Liability, to be Paid, Year Four 487K USD +4.96%
Operating Lease, Payments 1.47M USD -7.84%
Additional Paid in Capital 2.02B USD
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 2.6M USD +8.33%
Depreciation, Depletion and Amortization 1.28M USD -19.5%
Deferred Tax Assets, Net of Valuation Allowance 1.31M USD -79.7%
Share-based Payment Arrangement, Expense 138M USD +20.8%
Interest Expense 87M USD +8.01%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%